REMIKAF is contraindicated: For epidural or intrathecal administration due to the presence of glycine in the formulation [see Nonclinical Toxicology under Precautions].
In patients with hypersensitivity to remifentanil (e.g., anaphylaxis) [see ADVERSE REACTIONS].
                                
                            Other Services
                            
                            
                            Country
                            Account
                            
                        
                
                                    
                                            
 Sign Out